DAPI Merge

SUPPLEMENTARY METHODS
Human ESC Culture in Chemically Defined Conditions
Cells were differentiated as described in Bernardo et al., 2011 . H9 hESCs were cultured in a chemically-defined medium (CDM) supplemented with Fgf2 (20 ng/ml for differentiation and 12 ng/ml in pluripotency conditions) (recombinant zebrafish protein, made in the laboratory of Dr. Marko Hyvönen, University of Cambridge), 10 μM LY294002 (Sigma), 200 ng/ml Noggin (R&D Systems), 10 μM SB431542 (Tocris), 10 ng/ml (FLyB) or 50 ng/ml (FB) Bmp4 (R&D Systems) and either 10 ng/ml (pluripotency) or 100 ng/ml (FLyA) Activin A (made in the laboratory of Dr. Marko Hyvönen, University of Cambridge). Posterior (lateral plate) mesoderm differentiation was induced by treating cells with FLyB for 36 hours followed by Fgf2 + Bmp4 (50 ng/ml) for another 36 hours. All experiments were repeated at least twice on different cell passages to ensure results were reproducible.
Human ESC knockdown and overexpression lines
Stable H9 hESC sub-clones of BRA knockdown or BRA over-expression were established using a pLKO.1-puro shRNA vector (Sigma) or a pTP6 BRA-ER T2 vector, respectively. Briefly, the pTP6 BRA-ER T2 vector was generated by using the pTP6 PDX1-VP16-ER T2 vector (Bernardo et al., 2009 ) and replacing the PDX1-VP16 sequence with the BRA coding sequence (BRA ORF cDNA, Origene, RC218530). A Scrambled pLKO.1-puro shRNA vector (Sigma) was used as a control for the knockdown experiments whereas an "empty" pTP6 ER T2 vector was used as a control for the over-expression experiments. All vectors were introduced into H9 cells using Lipofectamine 2000 (Invitrogen) transfection following the manufacturer's instructions. After transfecting the vectors, colonies were allowed to grow for 24-48 hours before the addition of 1 µg/ml puromycin to the cultures. After approximately one week of antibiotic treatment, surviving colonies (sub-clones) were manually picked and expanded for further analyses. In the over-expression experiments, 1 µM 4-hydroxytamoxifen (Sigma) was added to the cultures in the beginning of the differentiation protocol and maintained for 36 hours. Puromycin (Sigma) was added to the media in all experiments involving vector-transfected cells. Stable clones were screened by qRT-PCR and immunostaining (BRA expression) and compared to control transfected lines.
Flow cytometry
Cells were briefly washed with PBS and incubated for 5 minutes in Cell Dissociation Buffer (Gibco, 13150-016) at room temperature. After an additional wash in PBS, the suspended cells were fixed using the Cytofix/Cytoperm kit (BD Biosciences, 555028) following the manufacturer's instructions. After fixation, the antibodies directly conjugated to a fluorophore were added first: anti-BRACHYURY coupled to Phycoerythrin (R&D Systems, IC2085P) and anti-SOX17 coupled to Allophycocyanin (R&D Systems, IC1924A). The antibodies that were not directly conjugated to a fluorophore [mouse anti-CDX2 (Biogenex, MU392A-UC) and rabbit anti-EOMES (abcam, ab23345)] were added subsequently at a 1/200 dilution. This was followed by the addition of donkey secondary antibodies conjugated to Alexa Fluor 488 (donkey anti-mouse, or donkey anti-rabbit at a 1/400 dilution) (Invitrogen). Where required, an intermediate blocking step was performed.
Each antibody incubation was done at 4°C for 30 minutes in blocking buffer (made in Cytoperm buffer) and was followed by 3 washes in Cytoperm buffer. Lastly, cells were re-suspended in PBS supplemented with 1% BSA. The appropriate isotype controls, primary antibody omission controls and cells-only controls, as well as single positive samples for each channel were included as controls.
Immunofluorescence
Cells were fixed for 15 minutes at room temperature in 4% paraformaldehyde (PFA) (Sigma) and then washed three times with PBS. Cells were blocked and permeabilised with PBS containing 10% donkey serum (Serotec) and 0.1% Triton-X (Sigma) for 30 minutes at room temperature. Subsequently, cells were incubated overnight at 4°C with primary antibodies diluted 1/100 in PBS with 1% donkey serum [goat anti-BRACHYURY (R&D Systems, AF2085) and rabbit anti-EOMES (abcam, ab23345)]. Cells were then washed three times with PBS and incubated with the appropriate secondary antibody (Alexa Fluor, Invitrogen) diluted 1/300 in PBS with 1% donkey for 1-2 hours at room temperature. The cells were washed three times with PBS. Nuclear stain was provided by adding DAPI in the first wash at a 1/10000 dilution.
Endogenous Protein Co-Immunoprecipitation
All buffers contained 20 mM Hepes, 0.2 mM PMSF, 0.5 mM EDTA, Complete protease inhibitor mix (Roche), 0.2 mM DTT and varying concentrations of Glycerol (G), KCl (K) or Sucrose (S), where K20 stands for 20 mM KCl, N50 for 50 mM NaCl, S250 for 250 mM Sucrose, etc. Cells were harvested in Cell Dissociation Buffer (Gibco) and lysed in ice-cold K20G5 using a Dounce homogenizer with 20 strokes. Nuclei were washed in isotonic K20S250, re-suspended in two volumes of K10G20 and extracted by addition of 400mM NaCl, douncing and subsequent rotation for 1h at 4°C. Chromatin and debris were separated from the nuclear extract (supernatant) by ultracentrifugation at 12000g and then dialyzed against K100N50 to establish near physiological salt conditions. Co-immunoprecipitation was carried out with antibodies indicated in the figure legends [R&D systems: SMAD1 (AF2039), SMAD2/3 (AF3797), control IgG (AB-108-C)] followed by ProteinG beads (Roche) and final washes in K100G10+0.02%Tween20. Samples were subsequently eluted in LDS sample buffer (Invitrogen) and run on a SDS polyacrylamide gel in preparation for analysis by immunoblotting. Volumes loaded: 5%-10% (Input), 50% (Immunoprecipitate).
Western blotting
Protein samples were loaded onto 4-12% sodium dodecyl sulphate-polyacrylamide gels (SDS-PAGE). Electrophoresis was carried out with an XCell SureLock Minicell system (Invitrogen) according to the manufacturer's instructions, using NuPAGE MOPS running buffer (Invitrogen). Samples were then transferred to PVDF membranes (Millipore). Immunodetection was performed according to manufacturer's instructions (Millipore) using the following primary antibodies (1/1000-1/5000 dilution): BRACHYURY (R&D Systems, AF2085), EOMESODERMIN (abcam, ab23345), SMAD1 (R&D Systems, AF2039), SMAD2/3 (R&D Systems, AF3797), Phospho-SMAD1/5/9 (Cell Signalling, 13820), Phospho-SMAD2/3 (Cell Signalling 8828), β-ACTIN (Sigma, A3853), and α-TUBULIN (abcam, ab7291) in 5% non-fat dry milk dissolved in TBS-T (150 mM sodium chloride, 10 mM Tris pH8.0, and 0.1% Tween 20 dissolved in water). Detection was carried out with secondary ExactaCruz reagents (Santa Cruz) for Co-IP samples or secondary HRP-conjugated antibodies at 1/10000 dilution (SIGMA) for normal Western blots. Dura-West substrate (Thermo Scientific) was used to develop the immunoblots prior to X-ray film exposure, following the manufacturer's instructions.
Total RNA extraction
Cells were washed briefly with PBS before adding cell lysis buffer (RLT buffer, QIAGEN). Total RNA was then extracted using the RNeasy Mini kit (QIAGEN) following the manufacturer's instructions. During RNA purification, spin columns were incubated with RNase-free DNase (QIAGEN, 79254) to remove residual DNA. After washing, the purified RNA was eluted in 30 µl of DEPC-treated water (Ambion). Samples were assessed for RNA concentration and quality using a NanoDrop spectrometer. Purified RNA was stored at -80ºC for further analyses.
Sample preparation for Illumina BeadArrays
Total RNA was extracted from cultured cells using the RNeasy Mini Kit (QIAGEN) as described above. RNA was then amplified, biotin labelled, and hybridized to Human WG-6 expression BeadArrays (Illumina) using a BeadScanner/BeadStation (Illumina) according to the manufacturer's standard protocols (Illumina) at the Microarray Resources Centre, Department of Pathology, University of Cambridge. Three biological replicates were hybridized for each experimental condition.
qRT-PCR
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) mixtures were prepared using Fast SYBR Green Master Mix (Applied Biosystems, 4385614), according to the manufacturer's instructions. PCR reactions were performed in a 7500 Fast Real-Time PCR System (Applied Biosystems) following the manufacturer's instructions. Three µl of diluted cDNA (1/200) from each sample were analysed in duplicate wells for specific gene expression. Expression values were then normalized by the expression of the "house-keeping" gene Porphobilinogen Deaminase (PBGD) in each sample, which was analysed in the same PCR plate. Relative gene expression was assessed using the formula 2 -ΔCt , where the Ct value corresponds to the cycle (within the exponential phase of the PCR reaction) at which the fluorescence crosses the optimal threshold established by Applied Biosystems software before DNA concentration begins to plateau. The ΔCt is the difference between the Ct of the gene of interest and the Ct of PBGD. Error bars on all qPCR graphs represent standard deviation from three independent biological replicates. Student's t-tests (two-tailed assuming non-equal variance) were performed. Primer sequences can be found in Table S6 .
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described (Brown et al., 2011) with some modifications. Human ESCs (between 2 x10 7 and 5 x 10 7 ) were grown in 10 cm plates and differentiated in FLyA or FLyB conditions as previously described. Before crosslinking, the growth medium was aspirated and the cells were rapidly washed with PBS. Crosslinking was then carried out in two steps: 1) treating the cells with PBS supplemented with 10 mM Dimethyl 3,3′-dithiopropionimidate dihydrochloride (DTBP) (Sigma, D2388) and 2.5 mM 3,3′-Dithiodipropionic acid di(Nhydroxysuccinimide ester) (DSP) (Sigma, D3669) at room temperature for 15 minutes; 2) adding 1% formaldehyde (Sigma) and incubating it at room temperature for another 15 minutes. The crosslinkers were then neutralized by adding 0.125 M Glycine and incubating at room temperature for 5 minutes. Cells were then rinsed with cold PBS and harvested in cold PBS supplemented with protease inhibitors (Roche, 11873580001), 50 µg/ml PMSF (Sigma, 93482) and 1 µg/ml Leupeptin (Roche, 11017128001) using a cell scraper. The cells were resuspended in 2 ml of Cell Lysis Buffer (10 mM Tris pH 8.0, 10 mM NaCl, 0.2% NP-40) and incubated for 10 minutes on ice. After centrifugation (1800 rpm at 4 o C for 5 minutes), the nuclei were resuspended in 1.25 ml of Nuclear Lysis Buffer (50 mM Tris pH 8.1, 10 mM EDTA, 1% SDS) and incubated for 10 minutes on ice. The nuclear lysate was then diluted by adding 0.75 ml of IP Buffer (20 mM Tris-HCl pH8.0, 2 mM EDTA, 150 mM NaCl, 0.01% SDS, 1% Triton x-100) before sonication. The chromatin was sonicated using a Misonix 4000 to obtain DNA fragments between 200bp and 400bp in size, and the samples were subsequently diluted to a 5.5 ml final volume with IP Buffer. An "Input" sample (300 µl) was taken before immunoprecipitation for later processing. The samples were then incubated overnight at 4°C with 10 μg of antibody (specific or non-specific). Antibodies used: BRACHYURY (R&D Systems, AF2085), BRACHYURY (Santa Cruz, sc-20109), EOMESODERMIN (abcam, ab23345), SMAD2 (Cell Signaling, 5339S), SMAD1 (Cell Signaling, 9743S), control IgGs (Santa Cruz). One hundred µl magnetic Protein G Dynabeads (Invitrogen) were used per ChIP. The beads were previously washed with PBS, blocked overnight with 0.5% BSA in PBS and then added to the samples. After 4 hours of rotation at 4°C, the bead-chromatin complexes were retrieved using a magnetic rack (Invitrogen). The beads were then washed twice with Wash Buffer 1 (20 mM Tris pH8.0, 2 mM EDTA, 50 mM NaCl, 0.1% SDS, 1% Triton X-100), once with Wash Buffer 2 (10 mM Tris pH8.0, 1 mM EDTA, 0.25 M LiCl, 1% NP-40, 1% Deoxycholic acid, sodium salt), and twice with TE Buffer (10 mM Tris pH8.0, 1 mM EDTA). The chromatin was then eluted twice (15 minutes each) in 150 µl of Elution Buffer (100 mM NaHCO 3 , 1% SDS) using a thermomixer (Eppendorf) at 65°C (1000 rpm). To reverse the crosslinking and remove RNAs, the samples (ChIP and Input) were treated with 100 mM DTT (Fluka, 43819) for 30 minutes at 37°C, followed by treatment with 1 μl RNase A (1 mg/ml) (Invitrogen) and 18 μl 5 M NaCl at 65°C for 8-12 hours. To remove all the proteins and recover the DNA, samples were treated with 3 μl Proteinase K (20 mg/ml) (Roche) for 2 hours at 45°C, followed by phenol/chloroform DNA extraction and ethanol precipitation using GlycoBlue (Ambion). Finally, the DNA was resuspended in 50 μl (ChIP samples) or 100 μl (Input samples) of nuclease-free water (Ambion) for further analyses.
Preparation of Illumina ChIP-seq libraries
Preparation of ChIP-seq libraries was carried out using the ChIP-seq DNA sample kit (Illumina, IP-102-1001) according to manufacturer's instructions. Minor modifications included: 1) using 5 ng of DNA as starting material [DNA concentration was measured using a Qubit fluorometer (Invitrogen) according to the manufacturer's instructions], 2) diluting the Illumina adaptor mix 40x before use, as recommended by Schmidt et al. (Schmidt et al., 2009) , 3) using the DNA Clean & Concentrator-5 kit (Zima Research) throughout the protocol, 4) performing the final size selection of DNA fragments (200bp-250bp) using the E-gel SizeSelect (2% agarose) system (Invitrogen).
Sequencing of Illumina ChIP-seq libraries
Processing of the samples was carried out at the MRC National Institute for Medical Research in London. The quality assessment of the libraries was carried out using the Agilent 2100 Bioanalyser to verify 1) the absence of primer dimers and 2) that the selected DNA fragments had a single-peak distribution with the desired size (around 200 bp). The libraries were finally sequenced in a Genome Analyzer (Illumina), according to manufacturer's instructions.
ChIP-qPCR
One µl of eluted DNA from each ChIP sample was analysed in duplicate and normalized to the Input. Target enrichment was assessed using the formula (1+Primer  Efficiency) -ΔCt , as previously described (Aparicio et al., 2004; Mukhopadhyay et al., 2008) . The ΔCt is the difference between the Ct of the ChIP sample and the Ct of the Input sample. Primer sequences can be found in Table S6 .
Illumina BeadArray analysis -Data processing
Data provided in raw bead-level format was imported into the R statistical programming environment (http://www.r-project.org/). The background was corrected with the RMA algorithm (Irizarry et al., 2003) and summarized via the BeadArray package of the Bioconductor (http://www.bioconductor.org) suite of open-source bioinformatics software. Once imported and processed as described, profiles were log 2 transformed and quantile normalised using the Bioconductor:limma package.
Illumina BeadArray analysis -Differential expression
For each microarray probe-set, significant difference in expression between groups of sample profiles, including those from Bernardo et al. (2011) (FLyA-or FLyB-treated hESCs, 36 hours), was assessed using the moderated t-statistic of (Wettenhall and Smyth, 2004) , as implemented in Bioconductor:limma. To correct for multiple hypothesis testing on such a scale, significance p-values obtained for all probe-sets were corrected using the false discovery rate (FDR) method of Storey and Tibshirani (2003) and differential expression deemed significant at a false discovery rate (FDR) of 5% (q < 0.05). Shared EntrezGene IDs were used to quantify intersection between differentially regulated genes and BRACHYURY-bound regions (see ChIP-seq methods) and to create corresponding Venn diagrams.
Illumina BeadArray analysis -Data visualization
Heatmaps of comparative gene expression were created via application of the heatmap.2 method from Bioconductor:gplots to gene expression profiles as described above. For each probe-set, log 2 expression intensities were scaled to have zero mean and unit standard deviation across all samples present. In the case wherein a gene was represented by more than one microarray probe-set, a single probe-set was selected for display according to highest mean expression across all samples regardless of sample group (highest average signal). Table S1 : ChIP-seq data analysis of BRA-bound regions (peak location and gene annotation) Click here to Download Table S1   Table S2 : Gene ontology analysis of BRA-bound regions Click here to Download Table S2   Table S3 : Microarray gene expression profiling of BRA knockdown hESCs compared with wild-type hESCs Click here to Download Table S3   Table S4 : Gene ontology analysis of microarray data Click here to Download Table S4   Table S5 : Comparison between BRA target genes and RNA-seq data from mouse Bra-null embryos Click here to Download Table S5   Table S6 : Primers used for qRT-PCR and ChIP-qPCR Click here to Download Table S6 
